Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H7NO |
Molecular Weight | 109.1259 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CN=CC=C1
InChI
InChIKey=UMJSCPRVCHMLSP-UHFFFAOYSA-N
InChI=1S/C6H7NO/c1-8-6-3-2-4-7-5-6/h2-5H,1H3
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Characterization of endoperoxide and hydroperoxide intermediates in the reaction of pyridoxine with singlet oxygen. | 2002 Oct 16 |
|
Benzyl ether structure-activity relationships in a series of ketopiperazine-based renin inhibitors. | 2005 Nov 1 |
|
Reactions of sulphate radicals with substituted pyridines: a structure-reactivity correlation analysis. | 2007 Dec 3 |
|
Pyridine-catalyzed stereoselective addition of acyclic 1,2-diones to acetylenic esters: synthetic and theoretical studies of an unprecedented rearrangement. | 2008 |
|
Lead optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson's disease. | 2008 Nov 27 |
|
Development and validation of a specific and sensitive GC-FID method for the determination of impurities in 5-chlorovaleroyl chloride. | 2010 Nov 2 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID60223238
Created by
admin on Fri Dec 15 18:05:19 GMT 2023 , Edited by admin on Fri Dec 15 18:05:19 GMT 2023
|
PRIMARY | |||
|
XV2A2D8595
Created by
admin on Fri Dec 15 18:05:19 GMT 2023 , Edited by admin on Fri Dec 15 18:05:19 GMT 2023
|
PRIMARY | |||
|
7295-76-3
Created by
admin on Fri Dec 15 18:05:19 GMT 2023 , Edited by admin on Fri Dec 15 18:05:19 GMT 2023
|
PRIMARY | |||
|
230-730-7
Created by
admin on Fri Dec 15 18:05:19 GMT 2023 , Edited by admin on Fri Dec 15 18:05:19 GMT 2023
|
PRIMARY | |||
|
23719
Created by
admin on Fri Dec 15 18:05:19 GMT 2023 , Edited by admin on Fri Dec 15 18:05:19 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD